Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Cytotherapy|January 21, 2014
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of careFrancesco Saglio, Patrick J Hanley, Catherine M BollardJournal of Pediatric Hematology/Oncology|October 29, 2024
Emerging CART Therapies for Pediatric Acute Myeloid LeukemiaValeria Ceolin, Manuela Spadea, Vincenzo Apolito, et al.Pediatric Transplantation|January 29, 2022
HSCT with mismatched unrelated donors: Bone marrow versus peripheral blood stem cells sources in pediatric patientsMassimo Berger, Marta Barone, Manuela Spadea, et al.Pediatric Transplantation|August 27, 2020
Steroid-refractory acute graft-versus-host disease graded III-IV in pediatric patients. A mono-institutional experience with a long-term follow-upMassimo Berger, Rosanna Pessolano, Francesca Carraro, et al.Radiology Case Reports|June 17, 2016
The role of 18F-FDG PET/CT in pediatric lymph-node acute lymphoblastic leukemia involvementAngelina Cistaro, Francesco Saglio, Sebastian Asaftei, et al.Cellular Immunology|November 3, 2010
Tumor-associated-antigens or osteosarcoma cell line lysates: two efficient methods for in vitro generation of CTLs with special regard to MHC-I restrictionMichela Muraro, Oana Madalina Mereuta, Francesco Saglio, et al.Journal of Pediatric Hematology/Oncology|May 3, 2019
Outcome of Relapsed Pediatric Patients After Second Allogeneic Hematopoetic Stem Cell Transplantation: A Retrospective Study From a Single InstitutionMassimo Berger, Rosanna Pessolano, Francesca Carraro, et al.Transplantation Direct|October 14, 2021
Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute LeukemiasManuela Spadea, Francesco Saglio, Serena I Tripodi, et al.European Journal of Pediatrics|March 26, 2023
Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatmentManuela Spadea, Francesco Saglio, Valeria Ceolin, et al.Pediatric Transplantation|November 3, 2020
CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective multicenter studyMassimo Berger, Maura Faraci, Francesco Saglio, et al.Pageof 4